Markets:

Overview

News

Currencies

International

Treasuries

Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

15.02 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9

...

28 29 Next >

Top Russell 2000 Picks: 3 Small-Cap Stocks to Scoop Up This May ↗

May 10, 2024

Some of the top Russell 2000 stocks to buy are those that few investors pay attention to but offer great potential nonetheless.

Via InvestorPlace

Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine ↗

May 09, 2024

These biotech breakthrough stocks give investors a glimpse into medicine's future -- and massive moneymaking opportunities to boot.

Via InvestorPlace

MNMD Stock Earnings: Mind Medicine Misses EPS for Q1 2024 ↗

May 08, 2024

MNMD stock results show that Mind Medicine missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May ↗

May 05, 2024

We look at the performance of 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies during the first week of May and YTD.

Via Talk Markets

The Top 3 Small-Cap Stocks to Buy in April 2024 ↗

April 25, 2024

These top small-cap stocks offer investors diversification across multiple segments but boast a strong standing on their own merits.

Via InvestorPlace

This Small-Cap Stock Is Up 140% This Year and Here's Why It Can Go Even Higher ↗

April 25, 2024

For investors with a high level of risk tolerance, Mind Medicine could be an intriguing investment option.

Via The Motley Fool

Clinical-Stage BioTech Drug Stocks Portfolio Went Down 9% Last Week ↗

April 23, 2024

A look at the 10 clinical-stage AI-powered and psychedelic compound-based small-cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, their stock performances last week and...

Via Talk Markets

Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked' ↗

April 19, 2024

Via Benzinga

Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More ↗

April 17, 2024

Via Benzinga

Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More ↗

April 17, 2024

Via Benzinga

The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD ↗

April 15, 2024

The pharmaceutical industry is embracing AI to streamline drug discovery and researching the use of psychedelic compound-based ingredients for the treatment of, as yet, untreatable diseases.

Via Talk Markets

Topics Artificial Intelligence

Largest Psychedelic Drug Stocks Up Another 10% Last Week; Now Up 54% YTD ↗

April 12, 2024

The 5 constituents in the Psychedelic Compound-Based Drug Stocks Index were up 10.0%, on average, last week and are now up 53.9% YTD.

Via Talk Markets

Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday ↗

April 10, 2024

U.S. stocks were lower, with the Dow Jones index falling over 300 points on Wednesday.

Via Benzinga

Topics Stocks

Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session ↗

April 04, 2024

U.S. stock futures were higher this morning, with the Dow futures gaining by around 90 points on Thursday.

Via Benzinga

Topics Stocks

March Recap: Largest Psychedelic Drug Stocks Up Another 5% ↗

March 30, 2024

The 5 constituents in the munKNEE Psychedelic Compound-Based Drug Stocks Index were UP 5.4%, on average, in March and are now UP 39.9% YTD.

Via Talk Markets

Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence ↗

March 29, 2024

Via Benzinga

Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow ↗

March 27, 2024

Via Benzinga

Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More ↗

March 20, 2024

Via Benzinga

Topics Economy

Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

March 14, 2024

Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) rose sharply in today’s pre-market trading after the company reported February trading metrics.

Via Benzinga

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 13, 2024

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24...

Via Benzinga

FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement ↗

March 13, 2024

Via Benzinga

Psychedelic Compound-Based Drug Stock, Mind Medicine, Up 56% Last Week ↗

March 11, 2024

The FDA has granted breakthrough designation to Mind Medicine's program for the treatment of generalized anxiety disorder.

Via Talk Markets

What A Trip: Psychedelic Medicine Company MindMed Shares Rocket 50% After Positive Data ↗

March 10, 2024

Shares of clinical stage biopharmaceutical company MindMed were heavily monitored on Friday after the stock rocketed higher during Thursday's cash session by more than 51% on more than 30x the...

Via Talk Markets

MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds ↗

March 08, 2024

Via Benzinga

S&P 500 Gains 1%; Kroger Earnings Top Views ↗

March 07, 2024

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 250 points on Thursday. The Dow traded up 0.34% to 38,793.79 while the NASDAQ rose 1.63% to 16,292.61. The...

Via Benzinga

Topics Stocks

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 07, 2024

Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.

Via Benzinga

MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials ↗

March 07, 2024

Via Benzinga

What's Going On With MindMed Stock Thursday? ↗

March 07, 2024

MindMed shares are trading higher Thursday after the company received FDA breakthrough therapy designation and announced positive study data

Via Benzinga

Why Is MindMed (MNMD) Stock Up 32% Today? ↗

March 07, 2024

MindMed stock is heading higher on Thursday as MNMD investors celebrate it getting breakthrough designation from the FDA!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 07, 2024

Pre-market stock movers are worth checking out on Thursday to get an idea of the hottest stocks worth watching this morning!

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9

...

28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

Headline News about Mind Medicine (MindMed) Inc. - Common Shares

Starting at $3.75/week.

Subscribe Today